These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29735237)

  • 1. Relationships Between Physical Activity and Bone Density in People Living with HIV: Results from the SATURN-HIV Study.
    Perazzo JD; Webel AR; Alam SMK; Sattar A; McComsey GA
    J Assoc Nurses AIDS Care; 2018; 29(4):528-537. PubMed ID: 29735237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.
    Chisati EM; Constantinou D; Lampiao F
    PLoS One; 2020; 15(1):e0227893. PubMed ID: 31935270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
    Shao Y; Sun J; Kong K; Zhang R; Zhang R; Liu L; Wang J; Shen Y; Wu L; Zheng Z; Sun M; Qi T; Wang Z; Tang Y; Sun J; Song W; Yang J; Xu S; Zhao B; Shan F; Qin A; Lu H; Chen J
    Arch Osteoporos; 2024 Jul; 19(1):56. PubMed ID: 38954143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
    J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A; Pasquet A; Goujard C; Lion G; Durand E; Bayan T; Lachâtre M; Choisy P; Ajana F; Bourdic K; Viget N; Riff B; Quertainmont Y; Cortet B; Boufassa F; Chéret A
    AIDS; 2018 Nov; 32(18):2689-2696. PubMed ID: 30234605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy.
    Libois A; Clumeck N; Kabeya K; Gerard M; De Wit S; Poll B; Tondeur M; Rozenberg S
    Maturitas; 2010 Jan; 65(1):51-4. PubMed ID: 19939594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
    AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Amenorrhea and Low Hip Bone Mineral Density in Women Living With HIV-A Controlled Cross-sectional Study.
    King EM; Nesbitt A; Albert AYK; Pick N; Cote HCF; Maan EJ; Prior JC; Murray MCM;
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):486-495. PubMed ID: 31914005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J; Viget N; Drumez E; Cortet B; Robineau O
    Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T; Saksawad R; Bunupuradah T; Wittawatmongkol O; Chuanjaroen T; Ubolyam S; Chaiwatanarat T; Nakavachara P; Maleesatharn A; Chokephaibulkit K
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):477-83. PubMed ID: 22918157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
    Zeng YQ; Xiao J; Li CL; Wang Y; Zhang L; Pang XL; Wang D; Du J; Zhao HX
    Chin Med J (Engl); 2020 Dec; 133(24):2940-2946. PubMed ID: 33278100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    Natukunda E; Szubert A; Otike C; Namyalo I; Nambi E; Bamford A; Doerholt K; Gibb DM; Musiime V; Musoke P
    PLoS One; 2023; 18(7):e0288877. PubMed ID: 37471330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
    Hoy JF; Grund B; Roediger M; Schwartz AV; Shepherd J; Avihingsanon A; Badal-Faesen S; de Wit S; Jacoby S; La Rosa A; Pujari S; Schechter M; White D; Engen NW; Ensrud K; Aagaard PD; Carr A;
    J Bone Miner Res; 2017 Sep; 32(9):1945-1955. PubMed ID: 28650589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.
    Porcelli T; Gotti D; Cristiano A; Maffezzoni F; Mazziotti G; Focà E; Castelli F; Giustina A; Quiros-Roldan E
    Osteoporos Int; 2014 Sep; 25(9):2263-9. PubMed ID: 25056799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Communication: Low Muscle Mass Is Associated with Osteoporosis in Older Adults Living with HIV.
    Oursler KK; Iranmanesh A; Jain C; Birkett KL; Briggs BC; Garner DC; Sorkin JD; Ryan AS
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):300-302. PubMed ID: 31762303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
    Han W; Bai X; Wang N; Han L; Sun X; Chen X
    Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study.
    Hileman CO; Labbato DE; Storer NJ; Tangpricha V; McComsey GA
    AIDS; 2014 Jul; 28(12):1759-67. PubMed ID: 24871454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.
    Martin A; Moore C; Mallon PW; Hoy J; Emery S; Belloso W; Phanuphak P; Ferret S; Cooper DA; Boyd MA;
    AIDS; 2013 Sep; 27(15):2403-11. PubMed ID: 23921615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.